Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Danica Michaličková"'
Publikováno v:
Antibiotics, Vol 13, Iss 5, p 419 (2024)
This study aimed to characterize the impact of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics (PK) of meropenem in neonates and children and to provide recommendations for meropenem dosing in this specific population of patients.
Externí odkaz:
https://doaj.org/article/01f1b53461864bad84eb168a73d29268
Autor:
Jan Miroslav Hartinger, Danica Michaličková, Eliška Dvořáčková, Karolína Hronová, Elke H. J. Krekels, Barbora Szonowská, Vladimíra Bednářová, Hana Benáková, Gabriela Kroneislová, Jan Závora, Vladimír Tesař, Ondřej Slanař
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1394 (2023)
Peritonitis is a limiting complication of peritoneal dialysis, which is treated by intraperitoneal administration of antibiotics. Various dosing strategies are recommended for intraperitoneally administered vancomycin, which leads to large difference
Externí odkaz:
https://doaj.org/article/782c6215001449b6b728be4d3be716d0
Publikováno v:
Prague Medical Report, Vol 121, Iss 4, Pp 244-253 (2020)
The post-mortem toxicological findings may be misinterpreted, if the drug undergoes substantial post-mortem redistribution. As alprazolam is one of the most frequently evaluated drug for legal/forensic reasons in drug-related fatalities, we studied p
Externí odkaz:
https://doaj.org/article/f7ec6188efd84794b1fd3d892355da40
Autor:
Petr Šantavý, Martin Šíma, Ondřej Zuščich, Vendula Kubíčková, Danica Michaličková, Ondřej Slanař, Karel Urbánek
Publikováno v:
Antibiotics, Vol 11, Iss 11, p 1582 (2022)
The objectives of this study were to develop a population pharmacokinetic model of prophylactically administered cefazolin in patients undergoing cardiac surgery with and without the use of the cardiopulmonary bypass of both existing types—standard
Externí odkaz:
https://doaj.org/article/204a94f8d0c549c8b071938f2f04bdeb
Autor:
Danica Michaličková, Pavel Jansa, Miroslava Bursová, Tomáš Hložek, Radomír Čabala, Jan Miroslav Hartinger, David Ambrož, Michael Aschermann, Jaroslav Lindner, Aleš Linhart, Ondřej Slanař, Elke H.J. Krekels
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Pharmacokinetic data for riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) have previously been reported from randomized clinical trials, which may not fully reflect the population encountered in routine practice. The a
Externí odkaz:
https://doaj.org/article/ef606238e060400caea9f07c381f9f57
Autor:
Martin Šíma, Danica Michaličková, Pavel Ryšánek, Petra Cihlářová, Martin Kuchař, Daniela Lžičařová, Jan Beroušek, Jan Miroslav Hartinger, Tomáš Vymazal, Ondřej Slanař
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1156 (2021)
The aim of this prospective PK study was to evaluate the pharmacokinetics of ciprofloxacin dosed within the first 36 h (early phase) and after 3 days of treatment (delayed phase) using individual and population PK analysis. The secondary aim of the s
Externí odkaz:
https://doaj.org/article/91486b6d3d6040918d05e6001370afb4
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 301 (2021)
Phenobarbital is a first-line treatment of various seizure types in newborns. Dosage individualization maximizing the proportion of patients with drug levels in therapeutic range or sufficient treatment response is still challenging. The aim of this
Externí odkaz:
https://doaj.org/article/e8baca8396a04d90a00fc3d1e0cb9187
Autor:
Karel Urbánek, Petr Šantavý, Ondřej Zuščich, Vendula Kubíčková, Danica Michaličková, Ondřej Slanař, Martin Šíma
Publikováno v:
Journal of Chemotherapy. :1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e2050ba4c7a7754687d7a03cc38edf7
https://doi.org/10.1080/1120009x.2023.2170895
https://doi.org/10.1080/1120009x.2023.2170895
Autor:
Jelena Kotur-Stevuljevic, Brizita Djordjevic, Marija Kostic-Vucicevic, Nenad Dikic, Rajna Minić, Marija S Andjelkovic, Ondrej Slanar, Danica Michaličková
Publikováno v:
Journal of Strength and Conditioning Research
Michalickova, D, Minic, R, Kotur-Stevuljevic, J, Andjelkovic, M, Dikic, N, Kostic-Vucicevic, M, Slanar, O, and Djordjevic, B. Changes in parameters of oxidative stress, immunity, and behavior in endurance athletes during a preparation period in winte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29bcb6821d093110192d28c4bcba87ab
https://doi.org/10.1519/jsc.0000000000002780
https://doi.org/10.1519/jsc.0000000000002780
Autor:
Jan Hartinger, David Ambrož, Danica Michaličková, Jaroslav Lindner, Ondřej Slanař, Radomír Čabala, Aleš Linhart, Elke H. J. Krekels, Pavel Jansa, Michael Aschermann, Miroslava Bursová, Tomáš Hložek
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation, Vol 10 (2020)
Pharmacokinetic data for riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) have previously been reported from randomized clinical trials, which may not fully reflect the population encountered in routine practice. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac7f02de068d78e771091f48739613d
https://doi.org/10.1177/2045894019898031
https://doi.org/10.1177/2045894019898031